Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders
There are, still, limitations to predicting the occurrence and prognosis of neurological disorders. Biomarkers are molecules that can change in different conditions, a feature that makes them potential tools to improve the diagnosis of disease, establish a prognosis, and monitor treatments. Metaboli...
Main Authors: | Amanda Donatti, Amanda M. Canto, Alexandre B. Godoi, Douglas C. da Rosa, Iscia Lopes-Cendes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/10/10/389 |
Similar Items
-
Everything you always wanted to know about sex and Neurology: neurological disability and sexuality
by: Alejandro Nasimbera, et al. -
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
by: Margherita Grasso, et al.
Published: (2014-05-01) -
Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs
by: Simona Paladino, et al.
Published: (2018-07-01) -
No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders, United States, 2001–2010
by: Joseph D. Forrester, et al.
Published: (2015-11-01) -
Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
by: Giovanni Schepici, et al.
Published: (2020-04-01)